Reta ZPHC — 120 mg

Manufacturer: ZPHC (Zhengzhou Pharmaceutical Co. Ltd)
Active Ingredient: Retatrutide
Form: 5 lyophilized vials × 24 mg each (total 120 mg)
Category: Metabolic & weight‑management research compound

Storage & Handling

• Store refrigerated at 2–8 °C (35–46 °F)

• Protect from light; keep vials sealed until reconstitution

• Maintain cold‑chain integrity during shipping

• For research use only — not approved for human consumption outside supervised protocols
  
  

  Parameter	Standard Range	Notes
  Total content	120 mg	5 vials × 24 mg
  Administration	Subcutaneous injection	Abdomen, thigh, or upper arm
  Frequency	Weekly	Long half‑life supports once‑weekly dosing
  Weekly dose	2–5 mg	Escalated gradually in study protocols
  Timing	Morning (fasted)	Enhances appetite suppression and metabolic response
  Cycle length	16–28 weeks	Commonly studied duration
  Research focus	Appetite suppression, insulin sensitivity, weight‑loss	Triple incretin agonist